Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
Journal of Medicinal Chemistry
|
March 3, 2026
Discovery of mCMV280: An Oral Ectoparasiticide in the Isoxazoline Class with Reduced Mammalian Brain Exposure
Sarah E McComic, Katy B Wilson, Zhilin Li, et al.
Ebiomedicine
|
September 27, 2021
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
Rana Abdelnabi, Caroline S Foo, Suzanne J F Kaptein, et al.
Nature Communications
|
November 3, 2019
Neratinib protects pancreatic beta cells in diabetes
Amin Ardestani, Sijia Li, Karthika Annamalai, et al.
Angewandte Chemie (International Ed. in English)
|
August 18, 2017
Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes
Renhe Liu, Xiaoxuan Lyu, Sarah M Batt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 4, 2018
Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases
Marie Miglianico, Maarten Eldering, Hannah Slater, et al.
Antiviral Research
|
April 7, 2022
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect
Caroline S Foo, Rana Abdelnabi, Suzanne J F Kaptein, et al.
Molecular and Biochemical Parasitology
|
September 4, 2010
Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds
Gregory J Crowther, Alberto J Napuli, James H Gilligan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 19, 2013
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
Feng Wang, Dhinakaran Sambandan, Rajkumar Halder, et al.
Cell Reports
|
March 30, 2021
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication
Gustavo Garcia, Arun Sharma, Arunachalam Ramaiah, et al.
Journal of Medicinal Chemistry
|
April 25, 2012
Imidazolopiperazines: lead optimization of the second-generation antimalarial agents
Advait Nagle, Tao Wu, Kelli Kuhen, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
Journal of Medicinal Chemistry
|
March 3, 2026
Discovery of mCMV280: An Oral Ectoparasiticide in the Isoxazoline Class with Reduced Mammalian Brain Exposure
Sarah E McComic, Katy B Wilson, Zhilin Li, et al.
Ebiomedicine
|
September 27, 2021
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
Rana Abdelnabi, Caroline S Foo, Suzanne J F Kaptein, et al.
Nature Communications
|
November 3, 2019
Neratinib protects pancreatic beta cells in diabetes
Amin Ardestani, Sijia Li, Karthika Annamalai, et al.
Angewandte Chemie (International Ed. in English)
|
August 18, 2017
Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes
Renhe Liu, Xiaoxuan Lyu, Sarah M Batt, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 4, 2018
Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases
Marie Miglianico, Maarten Eldering, Hannah Slater, et al.
Antiviral Research
|
April 7, 2022
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect
Caroline S Foo, Rana Abdelnabi, Suzanne J F Kaptein, et al.
Molecular and Biochemical Parasitology
|
September 4, 2010
Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds
Gregory J Crowther, Alberto J Napuli, James H Gilligan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 19, 2013
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
Feng Wang, Dhinakaran Sambandan, Rajkumar Halder, et al.
Cell Reports
|
March 30, 2021
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication
Gustavo Garcia, Arun Sharma, Arunachalam Ramaiah, et al.
Journal of Medicinal Chemistry
|
April 25, 2012
Imidazolopiperazines: lead optimization of the second-generation antimalarial agents
Advait Nagle, Tao Wu, Kelli Kuhen, et al.
Page
of 11